Both in Surgical Instruments
NovoCure Limited vs LeMaitre Vascular
Over the past year NVCR returned +23.5% and LMAT returned −5.6%; their daily moves had a correlation of 0.06.
NVCR +23.5% LMAT −5.6%Growth of $1, one year, split-adjusted
| Metric | NVCR | LMAT |
|---|---|---|
| Price | $15.95 | $82.59 |
| Market cap | $1.86B | $1.89B |
| Today | −0.25% | −0.36% |
| 1 month | −9.6% | +2.9% |
| 6 months | +46.3% | −24.3% |
| Year to date | +23.4% | +1.8% |
| 1 year | +23.5% | −3.3% |
| Revenue growth (YoY) | +15.6% | +9.6% |
| Gross margin | 77.6% | 72.1% |
| Net margin | −8.5% | 24.2% |
| P/E (TTM) | — | 28.8× |
| Price / sales | 2.7× | 7.2× |
| Net cash | $244.7M | $207.1M |
| Dividend yield | — | 1.21% |
| Volatility (60d) | 74.4% | 64.3% |
| Short % of float | 11.2% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).